Cargando…
Inhibitor of IGF1 receptor alleviates the inflammation process in the diabetic kidney mouse model without activating SOCS2
OBJECTIVE: To explore the anti-inflammatory mechanism of IGF1R inhibitor in diabetic nephropathy. METHODS: C57/BL6 mice were reared with high-fat diet for 8 weeks, then were injected 30 mg/kg streptozotocin intraperitoneally to induce type 2 diabetes. After 8 weeks, the type 2 diabetes nephropathy m...
Autores principales: | Li, Jiayu, Dong, Rong, Yu, Jiali, Yi, Sun, Da, Jingjing, Yu, Fuxun, Zha, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141121/ https://www.ncbi.nlm.nih.gov/pubmed/30254418 http://dx.doi.org/10.2147/DDDT.S171638 |
Ejemplares similares
-
Acteoside alleviates UUO-induced inflammation and fibrosis by regulating the HMGN1/TLR4/TREM1 signaling pathway
por: Mao, Yan, et al.
Publicado: (2023) -
Verbascoside alleviates renal fibrosis in unilateral ureteral obstruction rats by inhibiting macrophage infiltration
por: Zhang, Guihua, et al.
Publicado: (2021) -
PM(2.5) exposure aggravates kidney damage by facilitating the lipid metabolism disorder in diabetic mice
por: Jiang, Yuecheng, et al.
Publicado: (2023) -
SOCS, Inflammation, and Autoimmunity
por: Yoshimura, Akihiko, et al.
Publicado: (2012) -
SOCS, inflammation, and cancer
por: Inagaki-Ohara, Kyoko, et al.
Publicado: (2013)